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Abstract
Background: Danish patients with musculoskeletal disorders are commonly referred for primary care physiotherapy
treatment but little is known about their general health status, pain diagnoses, clinical course and prognosis.
The objectives of this study were to 1) describe the clinical course of patients with musculoskeletal disorders
referred to physiotherapy, 2) identify predictors associated with a satisfactory outcome, and 3) determine the
influence of the primary pain site diagnosis relative to those predictors.
Methods: This was a prospective cohort study of patients (n = 2,706) newly referred because of musculoskeletal
pain to 30 physiotherapy practices from January 2012 to May 2012. Data were collected via a web-based
questionnaire 1–2 days prior to the first physiotherapy consultation and at 6 weeks, 3 and 6 months, from clinical
records (including primary musculoskeletal symptom diagnosis based on the ICPC-2 classification system), and from
national registry data. The main outcome was the Patient Acceptable Symptom State. Potential predictors were
analysed using backwards step-wise selection during longitudinal Generalised Estimating Equation regression
modelling. To assess the influence of pain site on these associations, primary pain site diagnosis was added to the
model.
Results: Of the patients included, 66% were female and the mean age was 48 (SD 15). The percentage of patients
reporting their symptoms as acceptable was 32% at 6 weeks, 43% at 3 months and 52% at 6 months. A higher
probability of satisfactory outcome was associated with place of residence, being retired, no compensation claim,
less frequent pain, shorter duration of pain, lower levels of disability and fear avoidance, better mental health and
being a non-smoker. Primary pain site diagnosis had little influence on these associations, and was not predictive of
a satisfactory outcome.
Conclusion: Only half of the patients rated their symptoms as acceptable at 6 months. Although satisfactory
outcome was difficult to predict at an individual patient level, there were a number of prognostic factors that were
associated with this outcome. These factors should be considered when developing generic prediction tools to
assess the probability of satisfactory outcome in musculoskeletal physiotherapy patients, because the site of pain
did not affect that prognostic association.
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Background
Musculoskeletal disorders are a common cause of ill-
health, with substantial personal, community and soci-
etal consequences [1, 2]. In Denmark, over 50% of the
adult population will have experienced pain or discom-
fort within the last 14 days, and 37% report that they
have been severely bothered by their pain [3]. Musculo-
skeletal pain is one of the most common reasons that
people seek medical help in primary care, with up to
30% having at least one contact with their general practi-
tioner due to musculoskeletal pain conditions over a
period of 18 months [4]. In Denmark, patients with
musculoskeletal pain are often referred for physiotherapy
treatment [5], but the general health status, distribution
of pain diagnoses and clinical course in these patients
has not been described.
Identifying prognostic factors and subgroups of pa-
tients who respond best to physiotherapy interventions
is considered an important research priority [6, 7].
Therefore, in the last two decades a large number of
studies have identified potential predictors of outcomes
in different musculoskeletal pain conditions [8–12]. Pre-
dictive factors can vary depending on differences in
study populations, settings, statistical procedures and
outcome measures [13].
Commonly used outcome measures in musculoskeletal
pain prognostic studies have been improvement in pain,
improvement in function or various definitions of ‘dis-
abling pain’, but there are reasons why outcome mea-
sures that tap into broader aspects of recovery might be
suitable alternative measures of outcome. The first rea-
son is that the relationship between pain and function is
strongly influenced by psychosocial attributes, such as
coping, catastrophisation, pain beliefs and pain self-
efficacy [14]. Secondly, because of the fluctuating clinical
course of much musculoskeletal pain, the relatively low
likelihood of complete recovery, and the high recurrence
rate [15], contemporary treatment includes a focus on
promoting active coping strategies despite pain and on
restoring functional activity [16], and therefore outcome
measures ideally would tap into these constructs. There-
fore, outcome measures that assess the acceptability of a
symptom state not only assess patients’ adaption to their
health condition but also are not restricted to a single
dimension of their condition.
The Patient Acceptable Symptom State (PASS) is mea-
sured using a question that assesses the level of symp-
toms beyond which patients consider themselves well
and, while it was originally developed for patients with
rheumatic disorders [17, 18], it may also be appropriate
for more broad use in musculoskeletal pain conditions.
To our knowledge, the PASS has not been previously ap-
plied as an indicator of a satisfactory outcome in pa-
tients with diverse musculoskeletal disorders referred to
primary care physiotherapy and the predictors associated
with this outcome have not been previously evaluated in
this context.
In addition, most prognostic factor research in muscu-
loskeletal pain has been centred on people with pain in
specific anatomical pain sites (e.g. low back pain, neck
pain or shoulder pain) [8–10]. However, there is a view
that some prognostic factors are likely to be similar, re-
gardless of the specific pain site. For example, a recent
systematic review that compared primary care prognos-
tic factors across different anatomical pain sites, found
that despite considerable heterogeneity between studies,
some factors consistently emerged across different re-
gional pain complaints [19]. As clinicians in primary
care often treat a variety of musculoskeletal pain pa-
tients, such knowledge is useful. These findings also sug-
gest that, as different regional pain syndromes share
similar prognostic attributes, in musculoskeletal pain
these may be more prognostic than the primary pain site
diagnosis itself [6].
Therefore, the three objectives of the study were to: 1)
describe the clinical management and course of Danish
patients referred to physiotherapy due to musculoskel-
etal pain, on the outcomes of pain intensity, disability
(activity limitation), sick leave and whether they per-
ceived their symptoms as acceptable at follow-up (satis-
factory outcome), 2) identify predictors associated with
satisfactory outcome, and 3) investigate the influence of
primary pain site diagnosis on the strength of those
associations.
Methods
Study design and population
This was a prospective cohort study conducted in primary-
care physiotherapy practices in Denmark. Denmark is di-
vided into five geographical regions, with each region ad-
ministering its own public hospitals and primary health
care services, including physiotherapy practices. A total of
30 physiotherapy practices in four regions (Capital Region
of Denmark, Region of Southern Denmark, Central
Denmark Region, Northern Denmark Region) participated
in the study. Each physiotherapist was requested to collect
completed questionnaires and clinical data on newly re-
ferred patients with musculoskeletal disorders in the
period from January 2012 to May 2012. Consecutive pa-
tients were invited to participate if they fulfilled the fol-
lowing inclusion criteria: aged 18 years or above, able to
understand Danish well enough to self-complete the ques-
tionnaires, not referred for home treatment, and not hav-
ing received physiotherapy treatment for the same
problem in the preceding 3 months. All participants
signed written informed consent forms and the study was
approved by the Danish Data Protection Agency (No.
2007-58-0010). As treatment was not affected by
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participation in the study, under Danish law, this study
did not need ethics approval (Act on Research Ethics Re-
view of Health Research Projects, October 2013) [20].
Data collection
Questionnaire and clinical data were collected using an
existing web-based clinical database (www.fysdb.dk). Pa-
tients who agreed to participate in the study were asked
to complete on-line questionnaires 1–2 days prior to the
first physiotherapy consultation (baseline) and at
6 weeks, 3 and 6 months follow up. Participants were
notified by e-mail when the follow-up questionnaires
were available for completion. The questionnaires in-
cluded items about education, weight, height, smoking,
and physical activity, as previously used in other Danish
population-based surveys [3]. Pain, disability, pain be-
havior, sleep and mental health were measured by the
following validated questionnaires: Standard Evaluation
Questionnaire (SEQ) [21–23], the Örebro Musculoskel-
etal Pain Screening Questionnaire (MSPQ) [24, 25] and
the Mental Health Scale – Five (MH-5) [26].
As patients who are referred to physiotherapy have di-
verse musculoskeletal disorders, we used a multidimen-
sional assessment tool (SEQ) that was not specific to
only one body region. The SEQ assesses pain, disability,
and sleep disturbance in three separate modules: SEQ-
pain [21], SEQ-disability [22] and SEQ-sleep [23]. In
contrast to most other musculoskeletal pain assessment
tools, it can be used with pain in the upper limbs, lower
limbs or spinal regions. As a Danish language version of
the SEQ was not available, as part of this study, the SEQ
modules were forward and back translated, cross-
culturally adapted and its measurement properties evalu-
ated using internationally recommended methods [27–
29]. Test-retest reliability of the Danish version of the
SEQ was deemed to be acceptable and construct validity
was described relative to validated region-specific scales
[30–34], with the results being similar to those in the
original language version [21, 23]. (See Additional file 1
for more detail). Lastly, information on health-related
income support, physiotherapy interventions received
and number of consultations was obtained by the Danish
National Register on Public Transfer Payments [35] and
the National Health Service Register [36],
Prognostic factors
Primary pain site diagnosis
At the initial physiotherapy consultation, the patients’ pri-
mary musculoskeletal pain site diagnosis was recorded
using the International Classification for Primary Care 2nd
edition (ICPC-2) system [37], which is reliable and valid
for classifying musculoskeletal disorders [38]. Prior to the
start of the study, all participating physiotherapists were
invited to attend a 4-h workshop to standardise the
method of data collection. Additional descriptions of the
data collection procedures were made available to clini-
cians via the on-line clinical registry software.
Potential prognostic variables
Based on previous literature [8, 19, 39], the following
candidate prognostic factors from four health domains
were included:
1) Sociodemographic factors which included sex, age,
educational level (categorised into unskilled, lower
level (<3 years), vocational and training, medium
level (3–4 years), higher level (>4 years), and other),
geographical region (i.e. the physiotherapy practice’s
location in one of four regions), information on
health-related income support received (classified
into none (no record of transfer payments),
temporary (sickness benefit, vocational rehabilitation
benefit, or cash benefit, except if due to
unemployment), permanent (disability pension, or
voluntary early retirement that may be due to health
reasons), flex-job (which is an income subsidised job
due to limited work capacity) or age retirement).
These definitions have been used to quantify social
and economic consequences of health-related dis-
ability in other prospective cohort studies [40, 41].
Furthermore, information on private health insur-
ance, any ongoing compensation claim (litigation)
for their current pain condition, or previous claim
was obtained;
2) Pain and Function were measured by the SEQ pain
and disability modules, which included (i) items on
duration of pain (<1 month, 1–3 months, 4–12
months and >12 months), frequency of pain
(constant, daily basis, 2–6 days a week, 1–4 times a
month and less often) and pain medication (several
times a day, once a day, 2–6 days a week, 1–4 times
a month, rarely, and never), pain location and
number of pain sites (shown on a pain chart), pain
intensity in body regions scored on a numerical
rating scale (0 = no pain, 10 = intolerable pain), (ii) a
subscale of pain during activity consisting of 12
items (0 = no pain, 10 = intolerable pain), and (iii) a
subscale of disability consisting of 12 items (0 = no
difficulties, 10 = not possible to perform) covering
activities of daily living in three sections, namely, the
upper, lower and spinal body regions, that were
converted into a sum score 0–100, where 0
represented no pain/no difficulties;
3) Psychological factors included (i) three questions on
fear of physical activity in leisure and work activities,
each scored on a 0 to 10 numeric scale (0 =
completely agree, 10 = completely disagree) and
added to become a sum score (0–30), (ii) one
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question on ability to cope and deal with pain (0 =
no possibility, 10 = completely) from the MSPQ [24,
42], (iii) the SEQ sleep module, which contained two
questions on sleep problems and influence of sleep
problems in daytime activity scored on a 0 to10
numeric scale (0 = no problems, 10 = severe
problems) converted into a sum score 0–100 [23],
and (iv) five questions on well-being scored on a 5-
point Likert scale from the MH-5 [26] converted
into a score 0–100 (0 = worst possible state); and
4) Health behaviour, including being a smoker, Body
Mass Index calculated from self-reported height and
weight, and days per week being physical active
>30 min scored on an 8-point scale ranging from 0
= none to 7 = every day.
Outcome
The main outcome was the Patient Acceptable Symptom
State (PASS) measured by a single-item question adapted
from the original question designed for rheumatology pa-
tients [17, 18], that has also been found useful as an out-
come measure for patients with knee and hip osteoarthritis
[43]. The wording of the question was ‘Taking into account
the many ways your pain affects your daily life, if you were
to remain for the next few months as you are now, would
you consider your current state to be satisfactory” The ques-
tion was answered by selecting either the ‘yes’ or ‘no’ box.
The capacity for the PASS to define the highest level of
symptom at which patients find their condition acceptable
[44] has been shown to be stable over time [45] and across
different patient-reported outcome domains (i.e. pain, func-
tion and global assessment) [43].
Data analysis
Descriptive statistics (percentages, means) were used to re-
port the clinical course. We calculated the number of miss-
ing values, follow-up response rates, and differences in
baseline characteristics between responders and non-
responders at each time point and across administrative re-
gions. For each time point, pain and disability scores, the
percentages of patients being on temporary health-related
benefits, and the proportion of participants who perceived
their symptoms as acceptable (PASS), were calculated and
change over time was analysed by longitudinal linear mixed
models for continuous variables and Generalised Estimat-
ing Equation (GEE) models for categorical variables [46].
Analysis of predictors for satisfactory outcomes was
performed by multivariable regression modelling (GEE).
Consideration of the number of variables to include in
multivariable model building was based on the rule-of-
thumb that a least 10 cases per variable were needed to
avoid over-fitting the model [47, 48]. Initially, candidate
variables were checked for their univariate association
with the outcome and for possible collinearity. Where
variables were highly correlated (>0.7), only one of the
variables was retained. For continuous variables, the log-
odds linearity assumption was checked; in case of non-
linearity, the variable was recoded as a categorical vari-
able. Next, a stepwise backward regression analysis was
performed. At each step, the variable with the highest p-
value was removed from the model until all remaining
variables had a p-value below 0.05. Then the variable
primary symptom diagnosis (ICPC-2 classification) was
added to the model and the models were compared. To
explore if the significance level would affect the inclu-
sion of variables, sensitivity analysis was performed by
repeating the stepwise backward regression analysis
using a p-value below 0.2 to retain variables. In addition,
the possible influence of further sub-grouping symptom
diagnosis was explored by reclassifying neck and low
back patients into those with or without radiating pain.
All statistical analyses were performed using Stata Ver-
sion 13 (StataCorp LP, College Station, TX, USA).
Results
Baseline characteristics
The flow of participants within the study is shown in Fig. 1.
A total of 4,885 patients who were referred to physiother-
apy matched the inclusion criteria and 2,706 (55%) con-
sented to participate in the study. Their baseline
characteristics are presented in Table 1. Missing values
did not exceed 3% for any baseline variable. Patients who
failed to complete any follow-up questionnaires were
more often men than women, unskilled or with lower
educational level, using pain medication, smokers, having
more co-morbidity, less physically active and having
higher pain, disability and psychological scores (p < 0.05).
Primary symptom diagnosis and treatment
The distribution of the primary pain site diagnosis
(ICPC-2 classification) is presented in Fig. 2. Low back
pain was the most prevalent classification, followed by
neck pain and shoulder pain. The 197 physiotherapists
treated a median of 18 patients (IQR 13 to 23) each. The
median number of treatments was 6 (IQR 3 to 10). Over
the whole group, the prevalence of physiotherapy treat-
ments used was exercise therapy 36%, manual therapy
36%, instruction/advice on home exercise 22% and the
use of other physical modalities (e.g. electrotherapy and
thermotherapy) 6%. At an individual patient level, the
treatment recorded over the course of treatment, in-
cluded exercise therapy at least once for 83% of patients
and, when combining exercise therapy and/or instruc-
tion/advice on home exercises, the prevalence was 95%.
Clinical course
On average, patient improvement at the 6-month
follow-up was 2.9 (95% Confidence interval CI 2.7 to
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3.0) on their pain intensity scores and 9.7 (95% CI 8.9 to
10.5) on their disability scores. The prevalence of being
on temporary health-related benefits was reduced from
12% at baseline to 8% at the 6-month follow up - a total
reduction of 4.1% (95% CI 3.0% to 5.3%) - when exclud-
ing patients who retired or received permanent health-
related income support. The percentages of patients per-
ceiving their symptoms as acceptable increased from
32% at 6 weeks to 43% at 3 months and 52% at 6 months
– an estimated difference of 19.1% (95% CI 16.3% to
21.7%) On average, patients who perceived their symp-
toms as acceptable had significantly better pain and dis-
ability scores at the three follow up time points than
those patients who did not perceive their symptoms as
acceptable, mean difference 1.8 (95% CI 1.7 to 2.0) for
pain intensity and 7.2 (95% CI 6.4 to 8.0) for disability.
Predictors of satisfactory outcome
Table 2 shows the results of the final multivariable
model, with and without the primary musculoskeletal
pain diagnosis variable. Nine predictors were identified:
geographic region, health-related income support,
compensation claim, duration of pain, frequency of pain,
disability level, fear avoidance beliefs, mental health and
smoking; with the outcome variable being patients who
perceived their symptoms as acceptable during the
course of the 6-month follow up. Adding the primary
symptom diagnosis to that model had little impact on
these associations, as no single pain diagnosis was pre-
dictive of a satisfactory outcome. For the selection of
variables, changing the significance level to 0.2 added
two additional predictors (gender and sleep problems),
but with minimal impact on other associations. Simi-
larly, sub-grouping patients with neck and low back pain
into those with radiating and non-radiating pain did not
affect the results.
Discussion
This study evaluated the clinical course, treatment,
prevalence of satisfactory outcome, and predictors of sat-
isfactory outcome in musculoskeletal physiotherapy pa-
tients, including the possible influence of a primary pain
site diagnosis on those predictors. Over the 6-month
follow-up period, statistically significant and clinically
Referred to physiotherapy treatment by general 
practitioner from January to May 2012
N=5,621 Inclusion criteria not meet n=736 
-Age <18 years n= 402
-Insufficient skills in Danish 
n=155
-Physiotherapy for same 
condition within last 3 months 
n=164
-Referred for home treatment 
n=15  
Invited to participate
n= 4,885
Declined to participate n = 1,604 
Scheduled for first consultation
n= 3,281
Excluded n= 575  
-No baseline questionnaire n=259
-No clinical assessment n=148
-No baseline questionnaire or 
clinical assessment n=101
-No record of physiotherapy in 
study period n=37  
-Died during follow up n=1
-Emigrated during follow up n=6
-Suspicion of serious illness (red 
flags) n=23   
Participated in the study
n= 2,706 (55% of invited patients)
Questionnaire completed at 6 weeks follow up
n= 1,952 (72%)
Questionnaire completed at 3 months follow up
n= 1,697 (63%)
Questionnaire completed at 6 months follow up
n= 1,383 (51%)
Fig. 1 Flow of participants through the study
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relevant improvements were observed across outcomes;
however, in keeping with the recurrent and fluctuating
nature of many musculoskeletal conditions, only 52% of
patients rated their symptoms as acceptable at 6 months.
A higher probability of satisfactory outcome was associ-
ated with geographic region, being retired, no compen-
sation claim, less frequent pain, shorter duration of pain,
lower levels of disability, lower levels of fear avoidance,
better mental health and being a non-smoker. Primary
pain site diagnosis had little impact on the strength of
these associations and did not add any significant pre-
dictive ability.
Methodological considerations
Our study included a large consecutive cohort of pa-
tients who were recruited from many physiotherapy
practices and therefore the results are likely to reflect
primary care musculoskeletal problems as they present
Table 1 Baseline characteristics (n = 2,706)
Socio-demographic
Geographical Regions, n (%)
Capital Region of Denmark 594 (22.0)
Region of Southern Denmark 735 (27.2)
Central Denmark Region 499 (18.4)
North Denmark Region 878 (32.4)
Female, n (%) 1.798 (66.4)
Age, mean (SD) 48.3 (15.1)
Education, n (%)
Unskilled 392 (14.8)
Lower level (<3 years) 596 (22.5)
Vocational and training 426 (16.1)
Medium level (3–4 years) 802 (30.3)
Higher level (>4 years) 315 (11.9)
Other 118 (4.5)
Health-related benefits, n (%)
None 1.776 (65.6)
Temporary 245 (9.1)
Permanent 181 (6.7)
Retired 504 (18.6)
Private health insurance, n (%) 798 (30.1)
Compensation claim (litigation), n (%) 139 (5.2)
Pain and Function
Pain duration
< 1 month 640 (24.2)
1–3 months 739 (27.9)
4–12 months 505 (19.1)
> 12 months 766 (28.9)
Pain score 0–10,mean (SD) 6.5 (2.3)
Number of pain sites 0–9, mean (SD) 2.8 (1.7)
Pain during activity score 0–100, mean (SD) 32.7 (20.6)
Disability score 0–100, mean (SD) 26.2 (20.0)
Frequency of pain, n (%)
Constant 979 (36.9)
Daily basis 1,341 (50.6)
2–6 times a week 212 (8.0)
1–4 times a month 76 (2.9)
Less often 42 (1.6)
Taking pain medication, n (%)
Several times a day 818 (30.9)
Once a day 243 (9.2)
2–6 times a week 518 (19.5)
1–4 times a month 383 (14.5)
Less often 226 (8.5)
Never 462 (17.4)
Table 1 Baseline characteristics (n = 2,706) (Continued)
Co morbidity, n (%)
1 591 (22.3)
2 or more 224 (8.5)
Previous episode, n (%) 1.357 (50.7)
Psychological factors
Fear avoidance 0–30, mean (SD) 15.8 (8.4)
Coping skills 0–10, mean (SD) 5.4 (2.8)
Sleep score 0–100, mean (SD) 35.3 (29.0)
Mental health score 0–100, mean (SD) 75.0 (17.6)
Health behaviour
Smoker, n (%) 532 (19.7)
Body Mass Index, mean (SD) 26.1 (4.7)
Physical activity ≥30 min.0–7 days, mean (SD) 4.1 (2.5)
Abbreviation: SD standard deviation
Fig. 2 Primary pain diagnosis (ICPC-2 classification) (n = 2669)*. *No
pain diagnosis recorded in 37 patients. Abbreviation: NOS = Not
Otherwise Specified
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to Danish physiotherapists. Information from several
data sources was combined (i.e. clinical data, question-
naire data and registry data) allowing the inclusion of a
broad variety of variables to describe the clinical course
and to identify predictors of outcome.
A limitation of this study is that 33% of the patients in-
vited to participate declined the offer and another 12% had
to be excluded due to incomplete data and for other rea-
sons. This modest participation rate may have affected the
generalisability of our findings, although it also reflects the
general difficulty of recruiting consecutive cohorts of pa-
tients from routine clinical practice. Such non-participation
rates are common in large population studies and there is
evidence from other Danish studies that the estimated asso-
ciations between variables may not necessarily be biased by
non-participation [49, 50]. In our case, missing values in
baseline variables were few, but response rates at the three
follow-up points were only moderate and there were identi-
fied differences between responders and non-responders.
Although we conducted analyses using all the available data
by use of longitudinal regression modelling, which is robust
to missing data [51, 52], this cannot preclude a selection
bias. Some would argue that when assessing prognosis, a
12-month follow up would be a preferable endpoint. How-
ever, the 6-month endpoint in the current study was chosen
as little additional change has been shown to occur beyond
this point in common musculoskeletal conditions, such as
low back pain [53]. We used an established diagnostic clas-
sification system and validated questionnaires; we also
chose a main outcome measure that is not commonly used
in prognostic studies, albeit that it might provide a more
meaningful outcome in patients with musculoskeletal disor-
ders. The concept underpinning the PASS is the level of
symptoms beyond which patients consider themselves well
(in a satisfactory state) rather than having just experienced
a change in symptoms. As this is a state of well-being char-
acterised by at least a state of partial remission, from a pa-
tient perspective, it can be considered a highly relevant
treatment goal [43, 45, 54]. Understanding factors that are
related to achieving and maintaining such a state would
provide useful information for daily clinical practice. That
significantly better pain and disability scores were observed
for patients who perceived their symptoms as acceptable at
three follow up points than those patients who did not per-
ceive their symptoms as acceptable, adds to the concurrent
validity of this outcome measure.
It could also be argued that diagnostic pain site labelling
according to the ICPC-2 system is too broad for musculo-
skeletal pain conditions, but repeating the analyses after re-
classifying neck and low back patients into those with or
without radiating pain did not change our results. While no
consensus exists on the best method to build models using
candidate predictors, some have argued that backward
elimination method that we used is the preferred method
[48]. Also, while the choice of significance level can effect
the number of variables selected, a sensitivity analysis
demonstrated that, if the significance level were changed,
Table 2 Results of multivariable analysis with rating symptoms
acceptable as outcome without (Model 1) and with inclusion of
primary pain diagnosis (Model 2)
Model 1 Model 2
Variables OR 95% CI OR 95% CI
Socio-demographic
Geographical Regionsa
Capital Region of Denmark 1.00 1.00
Region of Southern Denmark 1.14 0.92–1.41 1.16 0.93–1.43
Central Denmark Region 1.25 1.00–1.57 1.29 1.02–1.62
North Denmark Region 1.41 1.15–1.74 1.44 1.16–1.78
Health-related income supporta
None 1.00 1.00
Temporary 0.73 0.54–1.00 0.77 0.56–1.05
Permanent 0.77 0.54–1.10 0.78 0.55–1.11
Retired 1.18 0.97–1.43 1.22 1.01–1.48
Compensation claim
No 1.00 1.00
Yes 0.59 0.40–0.86 0.58 0.40–0.85
Pain and Function
Pain duration
< 1 month 1.00
1–3 months 0.59 0.48–0.73 0.59 0.48–0.72
4–12 months 0.46 0.37–0.58 0.46 0.36–0.58
> 12 months 0.49 0.39–0.60 0.49 0.39–0.60
Disability score 0–100b 0.99 0.99–1.00 0.99 0.99–1.00
Frequency of pain (Constant or daily)
No 1.00
Yes 0.68 0.54–0.86 0.67 0.53–0.85
Psychological factors
Fear avoidance 0–30b 0.98 0.97–0.99 0.99 0.98–1.00
Mental health score 0–100b 1.01 1.00–1.01 1.01 1.00–1.01
Health behaviour
Smoker
No 1.00
Yes 0.87 0.79–0.96 0.87 0.78–0.96
Primary pain diagnosis
Muscle/Limited function NOS 1.00
Neck 1.30 0.94–1.80
Upper back/Chest 0.90 0.60–1.34
Low back 1.00 0.73–1.37
Shoulder 0.95 0.66–1.35
Arm/Elbow/Hand 1.04 0.68–1.60
Hip 1.09 0.71–1.67
Knee 0.80 0.53–1.21
Thigh/Lower leg/Foot 0.85 0.58–1.25
ap-value < 0.05 for overall test performed with χ2 statistics, b OR per
1 unit increase in scores
Abbreviations: OR Odds Ratio, CI Confidence interval, NOS that was
Not Otherwise Specified
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two additional predictors would have been included (gen-
der and sleep problems) but this would not have substan-
tially altered the results and conclusion of the study.
Furthermore, although a large number of candidate vari-
ables were included in our study, the achievement of a sat-
isfactory outcome could also be related to other factors
that we did not measure, such as patients’ beliefs and ex-
pectations of treatment.
Clinical course
The distribution of gender, age, duration of symptoms and
primary pain site diagnoses in our study, is similar to that
found in a previous Danish study of patients referred to
physiotherapy [5], as well as cohorts of musculoskeletal
physiotherapy patients from other countries [55]. The over-
all improvement on the outcomes of pain intensity, disabil-
ity and sick leave (temporary health-related income
support) was similar in size to those previously observed in
musculoskeletal conditions such as low back pain [53] and
exceeded a common threshold of clinically relevant import-
ant change (i.e. > 30% improvement from baseline) [56].
However, the design of the current study does not allow
any judgments to be made about the effectiveness of
physiotherapy treatment, as considerable improvement in
musculoskeletal pain has been observed without any treat-
ment [57]. Only half of the patients rated their symptoms
as acceptable at 6 months, which is in accordance with pre-
vious findings in general practice - reporting pain and dis-
ability to persist in up to 60% in cohorts of primary care
patients with low back, shoulder, and upper extremity pain
[58–60]. Thus, despite the physiotherapy treatment in our
study, which almost always included active treatment strat-
egies, this relatively moderate success rate suggests either
that there is potential for improvement in treatment and/or
that musculoskeletal pain conditions are inherently difficult
to treat. Contemporary evidence would suggest that shifting
from a more traditional physiotherapy pain-centred treat-
ment paradigm to a more function-centred treatment ap-
proach focusing on improving function, teaching patients
to understand and cope with the episodic nature and fluc-
tuating pattern of musculoskeletal pain, may be key ele-
ments to improving the perception of a satisfactory
outcome in musculoskeletal physiotherapy patients.
Predictors of satisfactory outcome
In our study, a number of predictors associated with satis-
factory outcome were identified from diverse health do-
mains. Duration of symptoms, disability levels and
psychological factors have consistently been found to be as-
sociated with subsequent outcomes in multiple prognostic
studies in primary care [8, 9, 19]. We found symptoms of
shorter duration and less frequent pain to be also associ-
ated with a higher probability of satisfactory outcome,
consistent with previous studies of different outcomes.
The concept of categorising musculoskeletal pain as acute,
subacute or chronic by focusing on symptom duration has
more recently been challenged by longitudinal studies of
trajectories (patterns of change in pain over time) in low
back pain [61]. These studies suggest that most people with
low back pain have trajectories of either episodic, fluctuat-
ing or persistent pain, rather than one well-defined episode.
Whether these trajectories can be identified across muscu-
loskeletal pain conditions and thereby improve the predic-
tion of outcome needs further investigation, but approaches
that generalise across musculoskeletal conditions would
simplify clinical practice. Similar to our findings, being a
non-smoker has previously been shown to be associated
with a better prognosis among primary care patients seek-
ing care for upper extremity pain [62]. Whereas for other
pain sites, similar results have not been reported, partly be-
cause smoking has less frequently been included in prog-
nostic studies of musculoskeletal pain [8–12, 19, 63].
Socio-demographic variables that predicted outcome, in-
cluded compensation claim, geographic region and health-
related income support. Having an ongoing compensation
claim can be stressful and is a predictor of outcome in sec-
ondary care neck and back patients [64, 65]. Although, this
involves a very small group among musculoskeletal physio-
therapy patients, similar mechanisms could be influential in
primary care. The findings that patients were more likely to
perceive their symptoms as acceptable in the central and
northern geographic regions of Denmark and when retired
from the labour market, suggests the prognostic implica-
tions of within-country cultural differences and of having
no work life demands. Differences in prognostic influences
between countries have previously been reported in cohorts
of chiropractic spinal pain patients [66], but as far as we
are aware, these within-country geographical differences
in Denmark among musculoskeletal physiotherapy pa-
tients are a novel finding. Whether the higher probability
of achieving a satisfactory outcome in more sparsely pop-
ulated areas (North Region), when compared to densely
populated areas (Capital Region), is related to differences
in accessibility of physiotherapy services, treatment beliefs,
expectations or other factors needs further investigation.
Furthermore, the strength of the observed associations
was mostly modest and several of the strongest associa-
tions were for predictors which are constructs that are not
easily modifiable (e.g. duration of symptoms, compensa-
tion claims and geographical differences). This currently
presents a challenge for clinical practice and prognostic
research. Therefore, understanding what potentially modi-
fiable underlying factors may influence such constructs
may be an important future research aim [13].
Influence of primary pain site diagnosis
Primary pain site diagnosis had little impact on the predic-
tion of outcome. The prognosis of patients did not differ
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across the primary pain site diagnosis from that of patients
who were classified with non-specific muscular symptoms
and limited function. These results are supported by those
from cohort studies in the USA, showing anatomical pain
sites did not influence the predictive value of psychological
factors, such as fear avoidance beliefs and depressive symp-
toms, in patients seeking physiotherapy treatment for mus-
culoskeletal pain [67, 68]. Traditionally, clinical practice
prognosis and treatment has been based on medical diag-
noses but the central role of diagnosis has recently been
challenged in conditions such as musculoskeletal pain,
where other factors have been shown to be more influential
on the outcome [6]. In patients with musculoskeletal pain,
many symptoms (such as pain, stiffness, and pain interfer-
ence with work and daily routine) are common regardless
of where the primary pain site is. In musculoskeletal pain
conditions, prognosis seems to be less about ‘where you
have it’ and more about ‘how much pain and disability you
have and your pain perceptions’. Diagnosis is likely to be
most relevant in conditions where there is an available
treatment that effectively targets the causal pathways of a
specific disease. In health conditions such as musculoskel-
etal pain, physiotherapy treatment strategies largely depend
on the same strategies, such as advice, reassurance, manual
therapy and exercise, and therefore are probably better
understood and managed within a prognostic framework.
Conclusion
Among Danish musculoskeletal physiotherapy patients,
only one in two perceived their symptoms as acceptable at
6 months, despite the average improvement being above
the threshold for clinically important change. A number of
predictors of satisfactory outcome were identified, which
appear to be prognostic regardless of primary pain site
diagnosis and which may have a role in generic prediction
models for physiotherapy patients with musculoskeletal
pain. While clearly there is a role for studies of single-site
musculoskeletal pain, our results also support the need for
more research that offers insights into the drivers of recov-
ery regardless of pain site and provides generic tools to as-
sist the management of musculoskeletal pain, whether it be
single-site or multi-site.
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